
Ozempic Chemist Warehouse: PBS Price $25 AU
If you’ve been searching “Ozempic Chemist Warehouse” hoping to find a straightforward price, you’re not alone — thousands of Australians are trying to work out whether this popular diabetes and weight-loss jab fits their budget. The catch is that Ozempic’s cost depends on whether you qualify for the PBS subsidy, and Chemist Warehouse, like all Australian pharmacies, is bound by the same pricing rules. Here’s what you can realistically expect to pay.
PBS Price at Chemist Warehouse (General): $25.00 ·
Concession Card Price: $7.70 ·
Pre-2026 Price: $31.60 ·
Non-PBS Cost: ~$130/month ·
US List Price: $936
Quick snapshot
- Ozempic (1.34 mg/mL, 3 mL pen) listed on PBS with DPMQ $134.60 (PBS.gov.au)
- General patients pay maximum $25.00 per script from January 2026 (Find a Pharmacy)
- Concession card holders capped at $7.70 per prescription (Find a Pharmacy)
- Real-time Chemist Warehouse stock levels at specific locations
- Exact private (non-PBS) Ozempic price charged at individual stores
- Current availability status in 2026 following past shortages
- 8th Community Pharmacy Agreement took effect 1 July 2024 (Find a Pharmacy)
- PBS general charge reduced to $25 from 1 January 2026 (Find a Pharmacy)
- Concessional freeze extended to January 2029 (Find a Pharmacy)
- PBS price indexation begins 1 January 2027 (Find a Pharmacy)
- Annual co-payment adjustments likely to continue reducing patient costs (Find a Pharmacy)
- Weight-loss users face ongoing private pricing until PBS expands indication (Find a Pharmacy)
| Item | Value | Effective Date |
|---|---|---|
| Chemist Warehouse AU PBS Price (General) | $25.00 | 2026-01-01 |
| Concession Card Price | $7.70 | 2026-01-01 |
| Pre-2026 General Charge | $31.60 | pre-2026 |
| PBS DPMQ (Differential Price) | $134.60 | Current |
| PBS Safety Net (General) | $1,748.20 | 2026 |
| PBS Safety Net (Concessional) | $277.20 | 2026 |
How much is Ozempic at Chemist Warehouse?
Five pharmacies compete for your script, but Chemist Warehouse — Australia’s largest pharmacy chain by store count — doesn’t set its own Ozempic price for PBS patients. Under the Pharmaceutical Benefits Scheme, all approved pharmacies charge the same maximum co-payment, and Chemist Warehouse falls in line as a PBS dispenser.
Australia PBS Pricing
For patients with a valid PBS prescription (typically for type 2 diabetes management), the maximum out-of-pocket at Chemist Warehouse is $25.00 for general patients and $7.70 for concession card holders, according to Find a Pharmacy’s pricing breakdown. This reflects the changes from the 8th Community Pharmacy Agreement, which took effect 1 July 2024 and reduced PBS charges from 1 January 2026.
Ireland Pricing Range
Direct Chemist Warehouse Ireland pricing for Ozempic is not publicly listed in available sources. Peer-nation data from the Health System Tracker suggests Irish Ozempic costs likely fall in the range of European peer nations, which range from $83 (France) to $169 (Japan) monthly — well below the US list price of $936. However, specific Irish Health Service Executive (HSE) reimbursement data remains unclear from publicly available sources.
Ireland pricing references from available sources suggest €133–€155 range based on community pharmacy reporting, but this lacks direct government source confirmation. Check with your local Irish pharmacy for current dispensing fees.
Non-PBS Costs
If you’re using Ozempic for weight loss without meeting PBS eligibility criteria, expect to pay privately. myDr.com.au estimates private Ozempic prescriptions cost around $130 per month in Australia. This is roughly five times the subsidized PBS price — a premium that reflects the difference between approved diabetes use and off-label weight management.
The implication: Chemist Warehouse charges the PBS maximum for eligible patients, not a discount rate. If you’re not on the scheme, you’re looking at private market pricing with no government subsidy.
For Australians with diabetes, Chemist Warehouse charges the subsidized PBS maximum — $25 for general patients, $7.70 for concession card holders. Weight-loss seekers pay the full private price, roughly five times more.
Can I lose 10kg in 2 months with Ozempic?
Expected Weight Loss Timeline
Clinical data shows Ozempic (semaglutide) produces meaningful weight loss, but the pace varies significantly between individuals. The University of Sydney’s analysis notes that Ozempic is approved for type 2 diabetes management on the PBS — weight loss is currently off-label use in Australia. Wegovy, the higher-dose formulation specifically approved for obesity, is not yet available in Australia.
Losing 10 kg in two months would require roughly 1.6 kg per week — faster than what most clinical trials report for semaglutide. Typical trial results show 1–2 kg per month at standard doses, according to myDr.com.au’s comparison of GLP-1 medications. This slower pace reflects the drug’s mechanism: it suppresses appetite and slows gastric emptying rather than burning fat directly.
Factors Affecting Results
Individual outcomes depend on starting weight, dosage, diet, exercise adherence, and whether the patient has diabetes. Patients using Ozempic off-label for weight loss pay privately ($130/month), while those with type 2 diabetes can access it via PBS at $25 — a significant financial difference that doesn’t affect efficacy, only access.
What this means: If you need Ozempic for diabetes, Chemist Warehouse offers the subsidized rate. If you’re seeking it purely for weight loss, you’ll need a private prescription and should factor in the ongoing cost versus realistic outcomes.
Australia’s PBS subsidy makes Ozempic affordable for diabetes patients ($7.70–$25), but weight-loss users pay $130/month privately — roughly $1,560 annually — with no subsidy and no Medicare deduction.
Targeting 10 kg in two months exceeds what clinical trials demonstrate — most patients lose 1–2 kg monthly. Setting realistic expectations prevents disappointment and helps patients budget for the ongoing prescription costs.
How much weight can you lose in a month on Ozempic?
Average Monthly Loss
Based on clinical trial data from major GLP-1 agonist studies and Australian health commentary, monthly weight loss on Ozempic typically ranges from 1 to 2 kilograms per month at standard maintenance doses. The Healthline analysis of international Ozempic pricing references clinical outcomes alongside its cost comparisons, noting that the medication is most effective when combined with lifestyle changes.
Realistic Expectations
Setting aside the 10 kg in 2 months target, a more realistic monthly figure aligns with what’s documented across peer-reviewed clinical observations and health authority commentary: approximately 4–8% of body weight over 6 months. For a 100 kg patient, that translates to 4–8 kg total, or roughly 0.7–1.3 kg per month — slightly less than the upper end of the trial range.
The catch: Ozempic’s weight loss effects plateau for many patients after 6–12 months. The drug doesn’t create permanent metabolic change — it’s a management tool, not a cure. Discontinuation typically leads to weight regain.
Can my GP prescribe Ozempic for weight loss?
Prescription Requirements
Australian GPs can prescribe Ozempic, but PBS eligibility is restricted to patients with type 2 diabetes. The University of Sydney’s health policy analysis confirms that Ozempic is listed on Australia’s Pharmaceutical Benefits Schedule specifically for diabetes management — Wegovy, the higher-dose formulation designed for obesity, has not yet received TGA approval or PBS listing.
A GP can issue a private prescription for Ozempic to a weight-loss patient, but Medicare doesn’t cover it and the PBS subsidy doesn’t apply. The patient pays the full private price (~$130/month per myDr.com.au). Some specialists may also prescribe Ozempic for patients who meet certain metabolic criteria.
Off-label Use
Off-label prescribing is legal in Australia — a doctor can prescribe an approved medication for uses beyond its original indication. However, off-label use means the patient bears the full cost and the prescriber assumes clinical responsibility without PBS support.
Why this matters: If your GP prescribes Ozempic for weight loss, expect to pay privately. If you have type 2 diabetes with a valid clinical indication, the prescription qualifies for PBS subsidy and Chemist Warehouse dispenses at the capped price.
Will you lose belly fat on Ozempic?
Targeted Fat Loss
GLP-1 agonists like Ozempic don’t selectively target belly fat, but weight loss from these medications tends to reduce visceral fat — the deep abdominal fat associated with metabolic syndrome and cardiovascular risk. Health System Tracker analysis notes that Ozempic and Wegovy both reduce overall body weight, with visceral fat reductions occurring alongside subcutaneous fat loss.
Overall Effects
Clinical studies show Ozempic reduces total body fat percentage rather than spot-reducing any single area. The reduction in belly fat is a consequence of overall weight loss, not a targeted effect. For patients with metabolically unhealthy visceral fat (common in type 2 diabetes), this overall reduction still addresses the primary health risk.
The implication: You won’t selectively “melt belly fat” with Ozempic alone. But if combined with diet and exercise, the drug supports the overall caloric deficit needed to reduce visceral adiposity — the type most directly linked to cardiovascular and metabolic complications.
| Dose/Formulation | PBS Status | Typical Cost at Chemist Warehouse (PBS) | Private Cost (Est.) |
|---|---|---|---|
| Ozempic 0.25 mg/dose (starter) | PBS subsidized if eligible | $25.00 general / $7.70 concession | ~$130/month |
| Ozempic 0.5 mg/dose | PBS subsidized if eligible | $25.00 general / $7.70 concession | ~$130/month |
| Ozempic 1 mg/dose (standard maintenance) | PBS subsidized if eligible | $25.00 general / $7.70 concession | ~$130/month |
| Wegovy (semaglutide 2.4 mg, obesity-specific) | Not TGA approved / not PBS listed | Not available | Not applicable |
| Mounjaro (tirzepatide, GLP-1/GIP dual agonist) | Not PBS subsidized | Not PBS subsidized | ~$400/month (unconfirmed) |
What this means: Ozempic remains affordable for eligible diabetes patients across all doses, but weight-loss users pay privately regardless of which dose their GP prescribes.
Upsides
- Highly subsidized at $25 general / $7.70 concession for eligible diabetes patients
- Chemist Warehouse offers wide physical access across Australia
- Significant visceral fat reduction alongside overall weight loss
- Clinically proven for type 2 diabetes management with PBS subsidy
- Generous repeat allowance (up to 5 repeats per PBS item)
Downsides
- Weight loss use is off-label, costing ~$130/month privately
- Wegovy (higher dose) not yet available in Australia
- Real-time stock availability unconfirmed for 2026
- Chemist Warehouse online ordering shows Ozempic unavailable
- Side effects (nausea, GI issues) common in titration period
- Requires ongoing prescription — not a one-time treatment
| Specification | Detail |
|---|---|
| Active Ingredient | Semaglutide (GLP-1 receptor agonist) |
| Pen Concentration | 1.34 mg/mL, 3 mL pen |
| Available Doses | 0.25 mg, 0.5 mg, 1 mg per injection |
| PBS Item Code | 14163K / 12075M |
| Manufacturer | Novo Nordisk Pharmaceuticals Pty. Limited |
| PBS DPMQ | $134.60 |
| Maximum Repeats (PBS) | 5 repeats |
| Drug Classification | Alimentary Tract and Metabolism > Blood Glucose Lowering Drugs |
| PBS Safety Net (General) | $1,748.20 (2026 threshold) |
| PBS Safety Net (Concessional) | $277.20 (2026 threshold) |
How Ozempic Pricing Stacks Up Globally
Three countries, three wildly different price points — Australia’s PBS subsidy creates a dramatic contrast with the US market.
| Country | Monthly List Price (USD) | PBS/Subsidy Status |
|---|---|---|
| Australia (PBS general patient) | ~$25 AUD (~$16 USD equivalent) | Subsidized via PBS |
| Australia (PBS concessional) | ~$7.70 AUD (~$5 USD equivalent) | Maximum subsidy |
| Australia (private / off-label) | ~$130 AUD (~$85 USD) | Not subsidized |
| United States | $936 | Not universally subsidized |
| France | $83 | National health coverage available |
| United Kingdom | $93 | NHS coverage available |
| Japan | $169 | National health insurance |
The pattern: The US pays roughly 10 times more for Ozempic than Australia does under PBS. Health System Tracker estimates Australia’s Ozempic price is approximately one-tenth the American list price — a gap driven by government negotiation on the PBS and the 8th Community Pharmacy Agreement’s structural reforms.
The US pays $936/month for Ozempic while Australians with diabetes pay $25. That 37-fold difference doesn’t reflect drug quality — it reflects whether a government health system negotiates drug prices on behalf of patients.
What Ireland’s Missing in the Comparison
Irish Ozempic pricing lacks direct official confirmation in available sources. Community pharmacy reports suggest a range of €133–€155 per monthly course, according to pharmacy community data from evoke.ie referenced in health policy comparisons. However, this figure doesn’t appear in direct Irish Health Service Executive (HSE) pricing documentation.
What the data does confirm: Ireland’s pharmaceutical pricing generally aligns with other European Union nations, which fall well below US levels but above Australian PBS rates. Health System Tracker notes that peer nations with national health systems consistently negotiate lower drug prices than the US market.
The list price for one month of Ozempic in the U.S. ($936) is over 5 times that in Japan ($169), and about ten times more than in Sweden, the United Kingdom, Australia, and France.
— Health System Tracker (Policy Analysis Organization)
Ozempic is listed on Australia’s Pharmaceutical Benefits Schedule (PBS), so people with diabetes can get a three-week supply for A$31.60 ($7.70 for concession card holders) rather than the full price ($133.80).
— University of Sydney (Academic News)
The implication: Ireland likely falls between Australia and the US on Ozempic pricing, benefiting from EU procurement mechanisms — but Australian diabetes patients enjoy stronger government subsidy protection.
Related reading: Lion’s Mane Mushroom Benefits · How to Get Rid of Pimples
Frequently asked questions
What does a 30 day supply of Ozempic cost?
At Chemist Warehouse under PBS, a 30-day (four-injection) supply costs $25.00 for general patients and $7.70 for concession card holders. Off-label weight-loss users without PBS eligibility pay approximately $130 per month privately. The Ozempic pen (1.34 mg/mL, 3 mL) provides four weekly doses at standard 0.25 mg or 0.5 mg starting doses.
How Much Is Ozempic With & Without Insurance?
Australia doesn’t use private health insurance for PBS medicines — the government subsidy replaces insurance-based models. Without PBS eligibility (off-label weight-loss use), Ozempic costs approximately $130/month privately. With PBS eligibility (type 2 diabetes), the cost drops to $25 general or $7.70 concession per prescription. Private health insurance may cover some private prescription costs depending on extras cover, but this is not standard.
What organ is Ozempic hard on?
Ozempic is primarily metabolized by the kidneys, and clinical monitoring focuses on kidney function — particularly for patients with existing renal impairment. Common side effects affect the gastrointestinal system (nausea, vomiting, diarrhea), which usually resolve during titration. PBS product information includes contraindications for patients with a history of pancreatitis. Always discuss your medical history with your prescribing GP.
Can you get Ozempic without GP?
No — Ozempic requires a valid prescription in Australia, whether PBS-subsidized or private. You cannot purchase it over the counter. A GP or specialist must assess your clinical eligibility, diagnose or confirm the relevant condition, and issue the prescription. Telehealth services have expanded access to Ozempic prescriptions, but a clinical consultation is still required. Chemist Warehouse dispenses the medication upon presentation of a valid prescription.
How much is Ozempic in Boots Ireland?
Direct Boots Ireland pricing for Ozempic is not publicly confirmed in available data sources. Community pharmacy reports suggest costs in the €133–€155 range for monthly supplies, but this lacks direct Boots or HSE confirmation. For accurate current pricing, contact your local Boots pharmacy or Irish community pharmacy directly. Irish patients with diabetes may qualify for HSE medical card or Drugs Payment Scheme subsidies, which can significantly reduce out-of-pocket costs.
Is Ozempic available online from Chemist Warehouse?
Chemist Warehouse’s online store currently lists Ozempic as unavailable for online purchase. Patients must obtain the medication in-store at their local Chemist Warehouse pharmacy, presenting a valid prescription. Availability may vary by location and current supply conditions — contacting your local store directly is advisable before visiting.
What’s the difference between Ozempic and Wegovy?
Ozempic and Wegovy both contain semaglutide but at different doses and with different approved indications. Ozempic is approved for type 2 diabetes (PBS-subsidized in Australia) at doses up to 1 mg. Wegovy uses higher semaglutide doses (up to 2.4 mg) specifically approved for chronic weight management. Wegovy is not yet approved by Australia’s Therapeutic Goods Administration (TGA) and is not available in Australia — patients seeking weight-loss benefits can only access Ozempic off-label.
For Australians with type 2 diabetes, the price advantage is clear: $25 per prescription at Chemist Warehouse versus $936 in the US. But for weight-loss seekers, the absence of PBS subsidy transforms a manageable cost into a significant ongoing expense — roughly $1,560 annually without any Medicare rebate. The trade-off is real: access via subsidy requires a diabetes diagnosis, while private prescriptions carry the full financial burden.